Skip to content

Released Mar 5, 2012, before the open

10-K filed Mar 5, 2012, 65 days after period end · 0001144204-12-012786

Q4 2011 · 10-K
Revenue—
Net Income-$5.16Kno prior Q4 2010 on fileno prior Q3 2011 on file
EPS, diluted—
Operating Cash Flowderived-$7,295—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-K.

Same quarter

no prior Q4 2010 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR